the Shanghai headquarters of China's central bank said on Wednesday. It will allow private equity funds and projects in the Shanghai FTZ to raise capital in the zone and overseas to meet demand for cross-border investments, the People's Bank of China's ... ( read original story ...)
UPDATE 1-China FTZ to expand net money inflows – PBOC Shanghai branch
the Shanghai headquarters of China's central bank said on Wednesday. China will continue to open up its economy and will not change policies on attracting foreign investment, Premier Li Keqiang said on a visit to the Shanghai FTZ this week, according to ... ( read original story ...)
China Bank raises P9.6-B via LTNCD
Australia and New Zealand Banking Group Ltd. (ANZ), The Hong Kong and Shanghai Banking Corp. Ltd. (HSBC), and Standard Chartered Bank acted as joint lead arranger, joint bookrunner and selling agents for the transaction. China Bank, China Bank Capital Corp ... ( read original story ...)
Wowo Limited Reports Third Quarter 2016 Unaudited Financial Results
On September 3 rd, 2016, the Company announced that it entered into a strategic cooperation agreement with Shanghai Chunmin Internet Financial Information Service Co., Ltd. (“Chunmin”), to jointly build a supply chain finance company to provide JM Wowo ... ( read original story ...)
China stocks reach a 10-1/2 month high, led by financial and energy shares
SHANGHAI Nov 22 China stocks advanced to a fresh 10-1/2 month high on Tuesday, helped by a strong rally in blue-chips, in particular financial and energy shares, after U.S. exchanges rose. The blue-chip CSI300 index rose 0.8 percent, to 3,468.36 ... ( read original story ...)
China's Fosun builds stake in Portugal's biggest bank
BCP said Fosun paid 175 million euros ($190 million) for 16.7 percent of the bank's capital. Fosun is considering extending its stake to around 30 percent. The Shanghai-based conglomerate owns Club Med and other businesses in Europe, including Portugal's ... ( read original story ...)
Shanghai FudanZhangjiang BioPharmaceutical Co., Ltd. 1349 Financial and Strategic SWOT Analysis Review Prices from USD $300
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b... ( read original story ...)